In myasthenia gravis (MG) an autoimmune response against muscle acetylcholine receptor (AChR) occurs. Embryonic muscle AChR contains a y subunit, substituted in adult muscle by a homologous e subunit. Antibodies and CD4 + cells specific for embryonic AChR have been demonstrated in MG patients.
Introduction
In myasthenia gravis (MG) 1 an autoimmune response against muscle nicotinic acetylcholine receptor (AChR) occurs (1) (2) (3) (4) .
Anti-AChR T helper (CD4', Th) cells can be propagated in 1 . Abbreviations used in this paper: AChR, muscle nicotinic acetylcholine receptor; APC, antigen presenting cells; FBAChR, fetal (embryonic) bovine muscle AChR; y Pool, a pool of synthetic peptides corresponding to the complete sequence ofhuman muscle AChR y subunit; MG, myasthenia gravis; TCM, tissue culture medium; Th, anti-AChR T helper cells.
vitro from the blood and thymus of MG patients (5) (6) (7) (8) (9) . They stimulate the production ofanti-AChR antibodies in vitro (10) and recognize the AChR in association with HLA-DR molecules (I I). Because Th cells recognize denatured AChR (6), they can be propagated in vitro using synthetic sequences ofthe AChR to yield polyclonal CD4+ T cell lines enriched in AChRspecific T cells (7, 12, 13) .
The AChR is a complex protein, formed in nonneuronal tissue by four homologous subunits (14) . Skeletal muscle AChR exists in two forms, whose expression is developmentally regulated (15) (16) (17) . An embryonic AChR is expressed before innervation occurs, whereas a different AChR is expressed by adult innervated muscle (15) (16) (17) . Both AChRs contain two a, one j3, and one 5 subunits ( 15) . Embryonic AChR also contains a Sy subunit, substituted in adult AChR by a homologous E subunit (15) (16) (17) . Adult mammalian thymus expresses a protein similar or identical to embryonic muscle AChR, containing a y subunit in addition to a, fl, and S subunits ( 18) .
We previously propagated Th cell lines specific for embryonic AChR from the blood of MG patients, using a pool of overlapping synthetic peptides corresponding to the complete sequence ofthe human y subunit ( 19) . This finding has ramifications for the pathogenesis of MG, because it has been proposed that the anti-AChR sensitization in MG may originate within the thymus (20) : the existence of MG patients of Th cells specific for embryonic AChR strongly supports this hypothesis. Further, antibodies specific for embryonic muscle AChR are frequently present in MG patients (21, 22) . A study that used junctional (i.e., adult) and extrajunctional (i.e., embryonic) rat muscle AChRs indicated that antibodies in MG patients recognized determinants either unique to embryonic AChR or common to both forms, never determinants unique to adult AChR (21 ) . Finally, a case of MG has been described where the antibodies recognized onlythe embryonic form ofrat muscle AChR (23) . The thymus of MG patients is frequently hypertrophic or it contains a thymoma (24) , and it contains anti-AChR Th and B cells (8, 25) . Thymectomy is beneficial for the evolution of MG and is a staple in the treatment of MG (26) .
In this study we sought to identify the sequence segments of the human AChR y subunit that form epitopes recognized by autoimmune CD4+ cell lines specific for embryonic AChR ( 19) , propagated from four MG patients ofdifferent HLA-DR type, by challenging the lines with individual overlapping peptides, spanning the complete sequence of the human AChR y subunit. For the sequence regions found to contain T epitopes, we searched for similarities with unrelated proteins to determine if the results reported here are compatible with the proposed origin of autoimmune responses from mechanisms of molecular mimicry between self components and microbial proteins (27) . Mg of each peptide/ml), PHA (10 Ag/ml; Wellcome Reagent Ltd., Beckenham, UK), FBAChR (5, 2.5, and 1.25,ug/ ml), or each individual synthetic peptide (10 ug/ml). Triplicate wells with blasts alone were seeded as controls. Blanks were wells with blasts plus APC and/or wells with blasts and APC plus 10 ,g/ml of a 19-residue synthetic peptide unrelated to the human y subunit (peptide E73, corresponding to residues 1-19 of the major intrinsic protein of bovine lens [35] ). 
Results
The CD4+ lines propagated from MG patients with the synthetic by pool are AChR specific. The specificity of the T cell lines for the AChR was tested by their ability to recognize FBAChR (Fig. 1) . AChR from bovine muscle is a good substitute for the exceedingly scarce human muscle AChR because it can be purified in sufficient amounts (34) and is highly homologous to human AChR ( 14, 30, 37) : the bovine y subunit is 92% identical to the human y subunit (30, 37) . Lines 2, 3, and 4 responded to 5 ,g/ml of FBAChR at least as strongly as to the highest concentration of y pool used (5 ,ug/ml ofeach peptide) whereas the response to FBAChR of line 1, although significant, was consistently lower than the response to the y pool.
Sequence segments ofthe human y subunit recognized by CD4' linesfrom MG patients. The segments of the y subunit sequence forming epitopes recognized by the CD4' cell lines were identified by challenging the lines with the individual synthetic peptides present in the y pool. The lines were tested for reactivity to the individual synthetic peptides as soon as a satisfactory enrichment in reactivity to y pool was achieved, i.e., when the response ofthe T cell lines to the hy pool in microproliferation assays was comparable to the response to PHA (Fig.  1 Response to y subunit synthetic sequences of CD4+ lines from healthy controls. We investigated the response to the individual peptides ofT cell lines that could be propagated for a few weeks from three normal subjects. Line from control 5 did not recognize any peptide detectably (data not shown) whereas lines from controls 3 and 4 responded to several peptides (see Fig. 4) . Control line 3 was tested three times: it clearly recognized several peptides (Hy75-94, Hy297-312, Hy321-340 and the overlapping peptides Hy470-489 and Hy476-495) only during the first experiment (Fig. 3 A) . Control line 4 had a slow rate of growth and could be tested only once (Fig. 3 B) .
Peptides Hy 165-184 and Hy476-495 were clearly recognized. The overlapping peptides, Hy 120-139 and Hy 135-154, elicited a low but significant response.
Similarities of the y subunit epitope-forming sequences with sequences of unrelated proteins. Several peptides recognized by the CD4+ lines had strong similarities with sequence regions from unrelated proteins, as summarized in Table III , where the y subunit peptide epitopes are aligned on the unrelated, similar sequences. Residues that are identical or conser- 10 ,tg/ml of the unrelated peptide E73 (****P < 0.001, ***P < 0.005, **P < 0.01, *P < 0.025). See text for experimental details. vatively substituted are indicated with boldfaced characters. Of the sequence pairs containing substantial similarities, we selected those containing sequence segments 10-16 residues long, with > 75% amino acids being identical or conservatively substituted. Insertions/deletions introduced to optimize the alignment were counted as extra positions. A length of 10-16 residues was chosen as a conservative compromise between the minimal length found in functional assays for class I-restricted T epitopes (5-7 residues [42, 43] ), and the length of the sequences found to bind to MHC molecules, [8] [9] residues for class I-presented peptides (44) (45) (46) (47) , and somewhat longer sequence segments for class II-presented peptides (48, 49) .
Discussion
We have identified here sequence segments of the human y subunit that form epitopes recognized by autoimmune Th cell lines specific for embryonic AChR, obtained from MG patients of different HLA-DR type. Other epitopes may have gone undetected because of the small size of the patient population, because of poor representation by our peptide panel, or because of selection of clones recognizing epitopes within peptides better processed into the relevant epitope and/or better able to bind the DR-restricting elements. Within these limitations, our approach permitted unambiguous identification of several epitopes. Fig. 4 summarizes the sequence regions of the y subunitcontaining epitopes recognized by the MG lines and the HLA-DR haplotype ofthe patients. The specificity ofthe lines for the epitope peptides was stable and was not a reflection ofthe duration of the culture because the pattern of peptide recognition remained consistent during propagation of the lines. Although some peptide sequences were recognized only by one line, as might be expected for Th cells ofdifferent HLA-DR haplotype, a substantial overlap existed in the epitope repertoires of the lines, and the sequences H-y75-94 and Hy32 1-340 were recognized by three lines. Immunodominant regions were previously identified along the AChR a subunit sequence, containing epitopes recognized by most MG patients irrespective of their HLA-DR haplotype ( 13, 41 ) . In multiple sclerosis a peptide corresponding to aminoacids 87-106 of the myelin basic use of long-term myelin basic protein-specific T cell lines allowed identification ofa core sequence (residues 89-99) recognized in the context of four different HLA-DR types (50) . Because T epitopes can be as small as 5-7 residues (42, 43), the sequence regions identified here may contain several nested T epitopes, as it occurs in sequence regions of similar or even shorter length from other protein antigens (51) (52) (53) (54) . Alternatively, one or more of these sequence segments may contain a single immunodominant T epitope, recognized within several or any MHC-class II haplotype as described for T epitopes on other proteins (39, 55) . The Th immunodominance of the regions identified here may be due to easier cleavage and processing, since they are probably located on the AChR surface (see below), and to the ability of human DR molecules to interact with unrelated peptides (56, 57) .
A potential caveat to the use oflong-term T cell lines is that selective clonal loss/enrichment may bias their repertoire.
Comparison of the repertoire of the lines with that of unselected blood CD4 + cells could not be done because, due to the paucity of AChR-specific CD4+ cells in the blood of MG patients (7), testing of blood CD4+ cells with AChR sequences is successful only in acutely, severely affected patients, never in the moderately affected patients from which the repetitive bleedings necessary for establishment of the lines can be obtained (7, 13) . Accordingly, unselected CD4+ cells from patients 3 and 4 did not detectably recognize any y subunit sequence. In favor ofgood concordance ofthe epitope repertoires of unselected CD4 + cells and of long-term Th lines is the finding that the sequence regions of the AChR a subunit recognized by unselected CD4+ cells of severely affected MG patients are very similar to those recognized by long-term AChRspecific lines propagated from moderately affected patients by the use of a peptide pool corresponding to the a subunit sequence (41) .
Patients 2 and 4 were donors ofcells used to establish anti-a subunit CD4+ T cell lines (13) . Comparison of the four T immunodominant regions of the a subunit sequence (Ha32-67, Ha 101-120, Ha304-337, Ha419-437: the latter segment corresponds to the carboxyl terminus of the human a subunit) (13, 41) with those identified here on the y subunit sequence, reveals a similar distribution of the T epitope segments along the a and the y subunit sequence. Four y subunit epitope peptides (Hy3O-49, Hy75-94, HFy321-355, and Hy470-489) have a sequence location similar to that of the immunodominant a subunit, although these segments are highly divergent in the a and the y subunit (Fig. 4) . In because ofthe presence of several charged and hydrophilic residues they may be exposed on the AChR surface. (60, 63) . Immunological cross-reactivity between viral or bacterial antigens and normal protein constituents of the host may be involved in development of autoimmune diseases, including MG, because microbial proteins and human autoantigens contain identical or similar sequence segments, which may form cross-reacting epitopes (27) . Some T epitope sequences of the AChR -y subunit resembled sequence regions ofother proteins, frequently of microbial origin (Table III) . This may indicate that molecular mimicry with microbial proteins is indeed involved in autoimmune responses or that some of our peptides were recognized as a result ofcross-reactivity, facilitated by the higher concentration of peptide in vitro compared with the in vivo conditions, of T cells sensitized against common viruses and bacteria. In support of the latter possibility the sequence Hy476-495, recognized by two control lines (Figs. 3 and 4) , has strong similarities with a protein component of the Herpes simplex virus, which is very common in humans. The relative high frequency of sequence similarities of AChR sequence regions with unrelated proteins is not surprising because certain short amino acid sequences (3-5 residues), presumably corresponding to specific tridimensional structural motifs, occur in the sequence of known proteins with a much higher frequency than statistically expected, and they have a propensity to cluster together, making it likely and indeed frequent that fragments of alien proteins up to 7-18 residues in length (i.e., enough for T epitope formation [43] [44] [45] [46] [47] [48] [49] Fig. 4 depicts alignments of the T epitope sequence segments of the -y subunit with the homologous segments of the other known subunits of human muscle AChR and of the y and E subunits of bovine muscle AChR. The bovine E subunit substitutes for the still unknown sequence of the human E subunit ( 14) . Some T epitope peptide sequences are highly diverged (e.g., Hy321-355 and Hy 411-430) and it is unlikely that the corresponding T cells cross-react with homologous segments of other AChR subunits. Others contain stretches of residues conserved or conservatively substituted in other AChR subunits (e.g., the sequences TLTNLISLN, FPFD-WQNCSL, SLKLTLLNILSNE, FPFDWQNCSLVF, and VVVLNVSLRSP, identical or almost identical in the y and E subunits) and may have stimulated and propagated T cells non--y subunit specific. This may explain the reported cross-reactivity of line 1 with both embryonic and adult AChRs (19) .
The preferential or unique response of the CD4+ cell lines to embryonic AChR (19) and the finding that several epitopes they recognize are within sequence regions highly diverged between the y and the other AChR subunits prove that these T cells are specific for embryonic AChR. Because embryonic AChR is not expressed by adult innervated muscle, this finding lends credence to the proposed origin ofthe anti-AChR sensitization in MG within the thymus (20) , which expresses an AChR similar or identical to embryonic muscle AChR, containing a y subunit (18) . Because the thymus AChR also contains a, ,B, and 6 subunits (18), T cells sensitized against epitopes formed by subunit present also in the more abundant muscle AChR may be preferentially expanded. Anti-y Th cells, as the disease progresses, may become a small fraction of the anti-AChR Th population and have a marginal role in the pro-duction of pathogenic anti-AChR antibodies. Still, their existence suggests a nonmuscle origin of the anti-AChR response.
Although the autoimmune Th response against AChR in MG is polyclonal, a limited sequence of at least two of AChR subunits, the a ( 13, 49) and the y subunits, seems to be involved in Th cell sensitization. This may allow development of specific immunosuppressive procedures, based on the use of synthetic peptides analogues, able to tightly bind to the class II molecules but unable to bind the T cell receptor ofthe autoimmune T cell and competing with the pathogenetic T epitope for their presentation, as it was successfully done in experimental autoimmune encephalomyelitis (66) (67) (68) . Availability of human autoimmune anti-AChR CD4' T cell lines and knowledge ofthe epitopes recognized are necessary steps towards this goal.
